COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,235 Articles (22,733 medRxiv, 8,502 bioRxiv)

Most recent first Previous |  Page 1324: Articles 13231-13240  | Next

Two-dimensional multiplexed assay for rapid and deep SARS-CoV-2 serology profiling and for machine learning prediction of neutralization capacity
Koide, A., Panchenko, T., Wang, C., Thannickal, S. A., Romero, L. A., Teng, K. W., Li, F.-Z., Akkapeddi, P., Corrado, A. D., Caro, J., Diefenbach, C., Samanovic, M. I., Mulligan, M. J., Hattori, T., Stapleford, K. A., Li, H. J., Koide, S.
10.1101/2021.08.03.454782 — Posted: 2021-08-04
A Master Autoantigen-ome Links Alternative Splicing, Female Predilection, and COVID-19 to Autoimmune Diseases
Wang, J. Y., Roehrl, M. W., Roehrl, V. B., Roehrl, M. H.
10.1101/2021.07.30.454526 — Posted: 2021-08-04
Azithromycin in patients with Covid-19; a systematic review and metanalysis
Ayerbe, L., Forgnone, I., Risco-Risco, C., Perez-Pinar, M., Ayis, S.
10.1101/2021.08.03.21261414 — Posted: 2021-08-04
A single intramuscular injection of monoclonal antibody MAD0004J08 induces in healthy adults SARS-CoV-2 neutralising antibody titres exceeding those induced by infection and vaccination
Lanini, S., Milleri, S., Andreano, E., Nosari, S., Paciello, I., Piccini, G., Gentili, A., Phogat, A., Hyseni, I., Leonardi, M., Torelli, A., Montomoli, E., Paolini, A., Frosini, A., Antinori, A., Nicastri, E., Girardi, E., Plazzi, M. M., Ippolito, G., Vaia, F., Della Cioppa, G., Rappuoli, R.
10.1101/2021.08.03.21261441 — Posted: 2021-08-04
Prospective cohort study of socioeconomic status and subsequent unemployment under COVID-19 in Japan
Kuroishi, M., Nagata, T., Hino, A., Tateishi, S., Ogami, A., Tsuji, M., Matsuda, S., Fujino, Y., Mori, K.
10.1101/2021.08.03.21261518 — Posted: 2021-08-04
Domestic and international mobility trends in the United Kingdom during the COVID-19 pandemic: An analysis of Facebook data
Shepherd, H. E. R., Atherden, F. S., Chan, H. M. T., Loveridge, A., Tatem, A. J.
10.1101/2021.08.03.21261545 — Posted: 2021-08-04
SARS-CoV-2 viral load monitoring by extraction-free testing of saliva
Qiu, Y., Lu, L., Gao, D., McGrath, P., Han, C., Kogut, I., Blomquist, B., Yao, X., Zevallos, J. P., Harry, B., Lu, S.-l.
10.1101/2021.08.02.21261502 — Posted: 2021-08-04
Lymphocyte count is a universal predictor to the health status and outcomes of patients with coronavirus disease 2019 (COVID-19): A systematic review and meta-regression analysis
Lai, K.-L., Hu, F.-C., Wen, F.-Y., Chen, J.-J.
10.1101/2021.08.02.21261505 — Posted: 2021-08-04
Comparative analysis of post-vaccination anti-spike IgG antibodies in old Nursing Home Residents and in middle-aged Healthcare workers
Jeulin, H., Craus, D., Labat, C., Benetos, A.
10.1101/2021.08.03.21261014 — Posted: 2021-08-04
COVID19 vaccine type and humoral immune response in patients receiving dialysis
Garcia, P., Anand, S., Han, J., Montez-Rath, M., Sun, S., Shang, T., Parsonnet, J., Chertow, G. M., Abra, G., Schiller, B.
10.1101/2021.08.02.21261516 — Posted: 2021-08-04

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).